Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry E Gidal

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Epilepsy Currents|October 15, 2010
Pharmacokinetic interactions with antiepileptic drugs: always the bad actor or simply misunderstood?Barry E Gidal
The American Journal of Managed Care|June 16, 2006
New and emerging treatment options for neuropathic painBarry E Gidal
Epilepsy Currents|September 2, 2016
Cannabidiol and Epilepsy: Sifting, Winnowing and BuzzBarry E Gidal
Epilepsy Currents|December 2, 2011
Carbamazepine hypersensitivity: progress toward predicting the unpredictableBarry E Gidal
Epilepsy Currents|December 19, 2013
Serotonin and epilepsy: the story continuesBarry E Gidal
Epilepsy Currents|February 23, 2016
Generic Substitution of AEDs: Is it Time to Put This Issue to Rest?Barry E Gidal
International Review of Neurobiology|April 17, 2007
Antiepileptic drug formulation and treatment in the elderly: biopharmaceutical considerationsBarry E Gidal
Current Neurology and Neuroscience Reports|June 12, 2009
Bioequivalence of antiepileptic drugs: how close is close enough?Barry E Gidal
Epilepsy Currents|October 9, 2015
Seeking the Rational (or at least avoiding the irrational)Barry E Gidal
Epilepsy Currents|February 28, 2012
Generic antiepileptic drugs: how good is close enough?Barry E Gidal
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Epilepsy Currents|October 15, 2010
Pharmacokinetic interactions with antiepileptic drugs: always the bad actor or simply misunderstood?Barry E Gidal
The American Journal of Managed Care|June 16, 2006
New and emerging treatment options for neuropathic painBarry E Gidal
Epilepsy Currents|September 2, 2016
Cannabidiol and Epilepsy: Sifting, Winnowing and BuzzBarry E Gidal
Epilepsy Currents|December 2, 2011
Carbamazepine hypersensitivity: progress toward predicting the unpredictableBarry E Gidal
Epilepsy Currents|December 19, 2013
Serotonin and epilepsy: the story continuesBarry E Gidal
Epilepsy Currents|February 23, 2016
Generic Substitution of AEDs: Is it Time to Put This Issue to Rest?Barry E Gidal
International Review of Neurobiology|April 17, 2007
Antiepileptic drug formulation and treatment in the elderly: biopharmaceutical considerationsBarry E Gidal
Current Neurology and Neuroscience Reports|June 12, 2009
Bioequivalence of antiepileptic drugs: how close is close enough?Barry E Gidal
Epilepsy Currents|October 9, 2015
Seeking the Rational (or at least avoiding the irrational)Barry E Gidal
Epilepsy Currents|February 28, 2012
Generic antiepileptic drugs: how good is close enough?Barry E Gidal
Pageof 9